Second-Line Therapy for Potentially Platinum-Sensitive Recurrent Ovarian Cancer: What Is Optimal Treatment?

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.81, Iss.1, 2001-04, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platinum-Resistant and Refractory Ovarian Cancer: Second-Line Treatment Options

By Alvarez A.A. Clarke-Pearson D.L.

American Journal of Cancer, Vol. 2, Iss. 1, 2003-01 ,pp. : 1-13

Adis International

Access to resources Recommend Favorite

Concerns with ''Maintenance Chemotherapy'' for Patients with Recurrent Platinum-Sensitive Ovarian Cancer

By Markman M.

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 469-470

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer

By Benedetti Panici Pierluigi De Vivo Antonio Bellati Filippo Manci Natalina Perniola Giorgia Basile Stefano Muzii Ludovico Angioli Roberto

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1136-1142

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Evaluation of 24-h Continuous Infusion Topotecan in Recurrent, Potentially Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Markman M. Blessing J.A. Alvarez R.D. Hanjani P. Waggoner S. Hall K.

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 112-115

Elsevier

Access to resources Recommend Favorite

Optimizing treatment of the partially platinum-sensitive ovarian cancer patient

By Colombo Nicoletta

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 19-23

Future Medicine

Access to resources Recommend Favorite